Disorders of the lower esophageal sphincter.
D000109:Acetylcholine / Q000627:therapeutic use; D014355:Chagas Disease / Q000150:complications / Q000503:physiopathology; D004176:Dipyridamole / Q000627:therapeutic use; D004931:Esophageal Achalasia / Q000503:physiopathology; D004935:Esophageal Diseases / Q000175:diagnosis*; D004938:Esophageal Neoplasms / Q000175:diagnosis; D004940:Esophageal Stenosis / Q000503:physiopathology / Q000628:therapy; D004932:Esophageal and Gastric Varices / Q000150:complications / Q000175:diagnosis; D004943:Esophagogastric Junction / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology; D005260:Female; D005764:Gastroesophageal Reflux / Q000503:physiopathology / Q000628:therapy; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D008013:Lidoflazine / Q000627:therapeutic use; D008297:Male; D008688:Methacholine Compounds / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D011312:Pressure; D012595:Scleroderma, Systemic / Q000150:complications / Q000175:diagnosis; D013035:Spasm
D008688:Methacholine Compounds; D004176:Dipyridamole; D008013:Lidoflazine; D000109:Acetylcholine